A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Abemaciclib
Sponsor: Eli Lilly and Company